MedTrace Logo

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

NCT04661657 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2022-06-06

No results posted yet for this study

Summary

COLUMBIA CARDS is a pilot study to understand how COVID-19 affects the heart. It is known that COVID-19 can affect the heart in different ways. COLUMBIA CARDS is studying why some COVID-19 survivors develop clinical conditions such as heart inflammation, fluid buildup, blood clots, and other cardiac problems during or after their COVID-19 illness, and why other ones do not. In this study, we will use cardiovascular magnetic resonance (CMR) and transthoracic echocardiography (TTE) to better understand the impact of COVID-19 on the heart.

Conditions

  • Covid19
  • Cardiac Disease
  • Cardiac Arrhythmia
  • Myocarditis
  • Left Ventricular Dysfunction

Interventions

OTHER

Transthoracic echocardiogram (TTE)

Subjects will undergo TTE imaging.

OTHER

Cardiovascular Magnetic Resonance (CMR) Imaging

Subjects will undergo CMR Imaging using a gadolinium based contrast agent (GBCA).

Sponsors & Collaborators

Principal Investigators

  • Andrew J. Einstein, MD, PhD · Columbia Univeristy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-28
Primary Completion
2022-01-22
Completion
2022-01-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04661657 on ClinicalTrials.gov